Drreddys Laboratories | RDY - الأصول





الأصول تغيير تاريخ
ANI Pharmaceuticals USD 1.42B 18.41M 2026-03
Aurora Cannabis CAD 775.29M 18.43M 2025-12
Bayer EUR 107.94B 3.4B 2026-03
Canopy Growth CAD 1.11B 36.35M 2025-12
Cipla INR 401.64B 27.77B 2025-09
Corcept Therapeutics USD 814.88M 21.77M 2026-03
Drreddys Laboratories INR 6.26B 161.9M 2025-12
GlaxoSmithKline GBP 62.87B 1.75B 2026-03
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Lonza CHF 18.97B 164M 2025-12
Novartis USD 118.53B 7.58B 2026-03
Pacira USD 1.21B 56.38M 2026-03
Phibro Animal Health USD 1.45B 39.56M 2026-03
Prestige Brands USD 3.49B 430K 2026-03
Richter Gedeon HUF 1.68T 39.69B 2025-12
Sun Pharmaceuticals INR 1.04T 116.06B 2025-09
Supernus Pharmaceuticals USD 1.5B 48.08M 2026-03
Teva Pharmaceutical Industries USD 40.04B 708M 2026-03